Skip to main content
Skip to main content
Home
About Us
Overview
Senior Leadership
Board of Directors
Advisory Board
Our Medicine
Overview
Talicia®
Expanded Access
Our Programs
Pipeline
Pipeline
Opaganib
RHB-204
RHB-107
RHB-102
Gastroenteritis & Gastritis
IBS-D
Oncology Support
Medical Grant & Investigator Initiated Study Requests
Investigator Initiated Study Requests
Medical Grant/Sponsorship
Medical Information
News
Investors
Overview
Events & Presentations
Press Releases
Financial Filings
Financial Reports
Annual Reports
SEC Filings
Stock Information
Stock Information
Analyst Coverage
Corporate Governance
Governance Documents
Partnering
Careers
Overview
Benefits
Contact
Contact Us
Email Alerts
Event Details
Home
About Us
Overview
Senior Leadership
Board of Directors
Advisory Board
Our Medicine
Overview
Talicia®
Expanded Access
Our Programs
Pipeline
Pipeline
Opaganib
RHB-204
RHB-107
RHB-102
Gastroenteritis & Gastritis
IBS-D
Oncology Support
Medical Grant & Investigator Initiated Study Requests
Investigator Initiated Study Requests
Medical Grant/Sponsorship
Medical Information
News
Investors
Overview
Events & Presentations
Press Releases
Financial Filings
Financial Reports
Annual Reports
SEC Filings
Stock Information
Stock Information
Analyst Coverage
Corporate Governance
Governance Documents
Partnering
Careers
Overview
Benefits
Contact
Contact Us
Email Alerts
World Orphan Drug Congress USA 2019
from April 10, 2019 to April 12, 2019
Gaylord National Harbor Hotel, Oxon Hill, MD
Speaker(s):
Patricia Anderson
,
VP, Regulatory Affairs
RedHill's presentation:
Date:
Friday, April 12, 2019
Time:
3:10 p.m. EDT
Add to Calendar
Add to Apple Calendar
Add to Google Calendar
Add to Microsoft Outlook
Add to iCalendar